SEPTEMBER 6–8, 2018 | LA JOLLA, CALIFORNIA

 

DEADLINE EXTENSION for ABSTRACTS

Due May 31

Early Registration Now Open

Register early and get a discount

David Althuler, MD, PhD

David Althuler, MD, PhD

Vertex Pharmaceuticals
Carlos Bustamante, PhD

Carlos Bustamante, PhD

Stanford University
Serena Nik-Zainal, MD, PhD

Serena Nik-Zainal, MD, PhD

Cancer Research UK Cambridge Institute
Andrew Plump, MD, PhD

Andrew Plump, MD, PhD

Takeda
JUST OVERALL VERY IMPRESSED WITH HOW WELL THE TECHNICAL AND THE CLINICAL CAME TOGETHER. VERY RELEVANT.
— 2017 Precision Health Meeting Attendee

I CAME AWAY WITH A RENEWED PASSION FOR THE WORK WE DO. IT WAS A GREAT OPPORTUNITY TO MEET PEOPLE WHO ARE IN THE SAME FIELD, BUT INTERACT IN DIFFERENT ROLES.
— 2017 Precision Health Meeting Attendee

I LOVED THE HIGH SCIENTIFIC CONTENT AND THE INTIMATE NATURE OF THE MEETING. EVERYONE WAS ACCESSIBLE.
— 2017 Precision Health Meeting Attendee

See the
See the
Think About

ATTEND IF YOU ARE

Scientists

Clinicians

Geneticists

Oncologists

Commercial scientists

Business sector leaders

Researchers

Bioinformaticians

ALL STAKEHOLDERS INTERESTED IN  ADVANCING THE INTERFACE OF GENOMICS, MEDICINE, AND HEALTH

ATTEND FOR

New discoveries in DNA sequencing technologies

Experimental and analytic approaches for genomic studies and applications

Clinical case studies Ground breaking research

The integration of genomics and pharmacogenomics to individualized patient care

Networking with top industry leaders

The Scientific
Organizing Committee

Michael Berger, Memorial Sloan Kettering Cancer Center
Wendy Chung, Columbia University
Paul Flicek, European Bioinformatics Institute
Geoffrey Ginsburg, Duke University School of Medicine
Eric Green, National Human Genome Research Institute
Elaine Mardis, Nationwide Children’s Hospital
Howard McLeod, Moffitt Cancer Center
Len Pennacchio, DOE Joint Genome Institute, Lawrence Berkeley National Laboratory
Heidi Rehm, Harvard, Broad Institute
Mike Talkowski, Harvard, Broad Institute